论文部分内容阅读
除出血性并发症外,血小板减少是应用未分馏肝素(UFH)的另一重要并发症,它是由抗体介导对抗肝素/血小板因子复合物反应所致,其发病率高达3％;而且它与静脉/动脉血栓栓塞事件的发生密切相关。尽管静脉注射UFH
In addition to hemorrhagic complications, thrombocytopenia is another important complication of the use of unfractionated heparin (UFH), which is caused by antibody-mediated responses to the heparin / platelet factor complex with a high incidence of up to 3%; and that it It is closely related to the occurrence of venous / arterial thromboembolism. Despite the intravenous injection of UFH